Post-market Clinical Investigation Plan: Collagen Dura Regeneration Membrane - Repair (DMR)
Monitoring the Use of Collagen Dura Membrane - Repair (DMR) in the Post-market Phase
1 other identifier
observational
110
0 countries
N/A
Brief Summary
Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2026
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
January 27, 2026
January 1, 2026
1.8 years
January 19, 2026
January 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of Revision Surgery
Rate of adverse events related to the Subject Device requiring surgical intervention.
at least one timepoint at 8 months or more post-surgery
Secondary Outcomes (4)
Rate of Adverse Events
at least one timepoint at 8 months or more post-surgery
Product Performance
at least one timepoint at 8 months or more post-surgery
Product Handling at Implantation
Initial surgery
Product Adaptability at Implantation
Initial surgery
Eligibility Criteria
All patients with a dural defect requiring repair with a dural substitute.
You may qualify if:
- Patients with a dural defect requiring repair with a dural substitute as per routine clinical practice
- Patient is 18 years or older
- Patient of child-bearing potential is not pregnant or nursing
- Participant is willing and able to provide consent
You may not qualify if:
- Patients with a known history of hypersensitivity to bovine derived materials
- Patients that are non-English speaking
- Patients requiring legal representation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Collagen Matrixlead
- Stryker Nordiccollaborator
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2026
First Posted
January 27, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
January 27, 2026
Record last verified: 2026-01